Shaanxi Meibang Pharmaceutical Group Co Ltd (SHG:605033) — Market Cap & Net Worth
Market Cap & Net Worth: Shaanxi Meibang Pharmaceutical Group Co Ltd (605033)
Shaanxi Meibang Pharmaceutical Group Co Ltd (SHG:605033) has a market capitalization of $456.81 Million (CN¥3.12 Billion) as of May 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #13053 globally and #4094 in its home market, demonstrating a 4.48% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shaanxi Meibang Pharmaceutical Group Co Ltd's stock price CN¥23.09 by its total outstanding shares 135200000 (135.20 Million). Analyse Shaanxi Meibang Pharmaceutical Group Co cash flow conversion to see how efficiently the company converts income to cash.
Shaanxi Meibang Pharmaceutical Group Co Ltd Market Cap History: 2021 to 2026
Shaanxi Meibang Pharmaceutical Group Co Ltd's market capitalization history from 2021 to 2026. Data shows growth from $511.91 Million to $456.81 Million (5.90% CAGR).
Shaanxi Meibang Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shaanxi Meibang Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.27x
Shaanxi Meibang Pharmaceutical Group Co Ltd's market cap is 0.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.46x
Shaanxi Meibang Pharmaceutical Group Co Ltd's market cap is 6.46 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $511.91 Million | $842.49 Million | $125.74 Million | 0.61x | 4.07x |
| 2022 | $330.48 Million | $906.05 Million | $145.09 Million | 0.36x | 2.28x |
| 2023 | $350.81 Million | $699.03 Million | $57.56 Million | 0.50x | 6.09x |
| 2024 | $238.00 Million | $885.53 Million | $36.86 Million | 0.27x | 6.46x |
Competitor Companies of 605033 by Market Capitalization
Companies near Shaanxi Meibang Pharmaceutical Group Co Ltd in the global market cap rankings as of May 7, 2026.
Key companies related to Shaanxi Meibang Pharmaceutical Group Co Ltd by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #485 globally with a market cap of $53.89 Billion USD.
- Nutrien Ltd (TO:NTR): Ranked #758 globally with a market cap of $35.25 Billion USD ( CA$48.73 Billion CAD).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #855 globally with a market cap of $31.28 Billion USD ( CN¥213.78 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1594 globally with a market cap of $15.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #485 | Corteva Inc | NYSE:CTVA | $53.89 Billion | $81.77 |
| #758 | Nutrien Ltd | TO:NTR | $35.25 Billion | CA$100.81 |
| #855 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $31.28 Billion | CN¥40.40 |
| #1594 | CF Industries Holdings Inc | NYSE:CF | $15.33 Billion | $119.76 |
Shaanxi Meibang Pharmaceutical Group Co Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Shaanxi Meibang Pharmaceutical Group Co Ltd's market cap moved from $511.91 Million to $ 456.81 Million, with a yearly change of 5.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥456.81 Million | +14.99% |
| 2025 | CN¥397.26 Million | +66.92% |
| 2024 | CN¥238.00 Million | -32.16% |
| 2023 | CN¥350.81 Million | +6.15% |
| 2022 | CN¥330.48 Million | -35.44% |
| 2021 | CN¥511.91 Million | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Shaanxi Meibang Pharmaceutical Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $456.81 Million USD |
| MoneyControl | $456.81 Million USD |
| MarketWatch | $456.81 Million USD |
| marketcap.company | $456.81 Million USD |
| Reuters | $456.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shaanxi Meibang Pharmaceutical Group Co Ltd
Shaanxi Meibang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, sale, and agricultural technology promotion, and service of pesticide products in China and internationally. The company offers pesticides, fungicides, herbicides, plant growth regulators, fertilizers, and microbial fertilizers. It is also involved in sale of agricu… Read more